Clinical significance of barriers to blood glucose control in type 2 diabetes patients with insufficient glycemic control
Takeo Suzuki,1 Ryoko Takei,2 Toyoshi Inoguchi,2,3 Noriyuki Sonoda,2,3 Shuji Sasaki,2 Toshihiko Kaise,1 Ryoichi Takayanagi21Development and Medical Affairs Division, GlaxoSmithKline K.K., Tokyo, 2Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, 3Innovati...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-06-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/clinical-significance-of-barriers-to-blood-glucose-control-in-type-2-d-peer-reviewed-article-PPA |